| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 06/29/2005 | EP1547605A1 Adsorbents for oral administration |
| 06/29/2005 | EP1545579A1 Compositions containing peptide copper complexes and phytochemical compounds, and methods related thereto |
| 06/29/2005 | EP1545523A1 3-&-grave;(HETERO) ARYLMETHOXY ! PYRIDINES AND THEIR ANALOGUES ASP38 MAP KINASE INHIBITORS |
| 06/29/2005 | EP1545430A2 Bispecific molecule comprising an anti-cr1 antibody cross-linked to an antigen-binding antibody fragment |
| 06/29/2005 | EP1443948B1 Process for the preparation of anthocyanin-containing products |
| 06/29/2005 | CN1633444A 6-11 bicyclic ketolide derivatives |
| 06/29/2005 | CN1633420A Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors |
| 06/29/2005 | CN1633416A Nicotinamide derivates useful as p38 inhibitors |
| 06/29/2005 | CN1633299A Estrogen replacement therapy |
| 06/29/2005 | CN1633294A 2, 4, 5-trisubstituded thiazolyl derivatives and their antiinflammatory activity |
| 06/28/2005 | CA2152280C Use of riluzole as a radiorestorer |
| 06/23/2005 | US20050137239 Thiazole derivatives |
| 06/23/2005 | US20050136041 Transgenic cell comprising nucleotide sequences coding erythropoietin and/or glucagon-like peptides for use in treatment and prevention of blood and metabolic disorders; somatic and germ cell gene therapy; tissue engineering |
| 06/23/2005 | DE60108272T2 Pharmazeutische zusammensetzung enthaltend (-)-secoisolariciresinol A pharmaceutical composition comprising (-) - Secoisolariciresinol |
| 06/22/2005 | EP1544207A1 Process for producing glycoside |
| 06/22/2005 | EP1543824A2 Thiazole derivatives to counter advanced glycation |
| 06/22/2005 | EP1542948A2 Novel biphenyl and biphenyl-like cannabinoids |
| 06/22/2005 | EP1411879A4 A composition and uses therefor for combating hangover |
| 06/22/2005 | EP1345933B1 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 06/22/2005 | EP1177200B1 Ligands for metabotropic glutamate receptors |
| 06/22/2005 | EP1131039B1 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress |
| 06/22/2005 | CN1630521A Oral compositions and methods for prevention, reduction and treatment of radiation injury |
| 06/22/2005 | CN1628787A Method for separating and extracting effective constituent from Sand Ginger by bi-enzyme method |
| 06/22/2005 | CN1628764A Creat formulation and its preparation process |
| 06/22/2005 | CN1207030C Natural bioreaction regulator with the functions of resisting cancer, resisting free radical damage and regulating immunity |
| 06/21/2005 | US6908942 Carbocyclic oxy amines such as 2,2-dimethyl-3-(4-fluorobenzyl) ether-4-methoxy-6-(4-methoxybenzyl)amino Benzopyran and libraries, used for prophylaxis of eating disorders induced by lipid peroxidation; antioxidants |
| 06/21/2005 | US6908614 Anti-aging/menopause symptoms relief using ganoderma lucidum spores |
| 06/21/2005 | US6908432 Methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug |
| 06/17/2005 | CA2479432A1 Thiazole derivatives |
| 06/16/2005 | WO1990000853A8 Method of treating neurological disorders |
| 06/16/2005 | US20050131047 cardiovascular disorders |
| 06/16/2005 | US20050130902 Upregulate expression of a gene encoding an antioxidative anzyme, such as superoxide dismutase or catalase; neurodegenerative, cardiovascular, cerebral, disorders, trauma, injuries, burns, cancer |
| 06/16/2005 | US20050130881 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
| 06/16/2005 | US20050129786 Topical composition having undifferentiated plant seed cells and method for using same |
| 06/16/2005 | US20050129667 treating leukemia or bone cancer by injecting a samarium comples of ethylenediaminetetramethanephosphonic acid and another chemotherapeutic agent; stem cell/bone marrow transplantation and/or restoration; patient is not subjected to total body irradiation |
| 06/16/2005 | CA2547887A1 Protein modifier production inhibitor |
| 06/15/2005 | EP1541672A1 Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 06/15/2005 | EP1541125A1 Spreadable compositions for topical use, a process of making same and uses thereof |
| 06/15/2005 | EP1539769A1 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 06/15/2005 | EP1539707A1 Method and compounds for promoting healing and reducing inflammation |
| 06/15/2005 | EP1539168A2 Treatment of neuropathic pain with 6h-pyrrolo(3,4-d)pyridazine compounds |
| 06/15/2005 | EP1439831B1 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect |
| 06/15/2005 | EP1114031B1 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 06/15/2005 | EP0885241B1 Purification method |
| 06/15/2005 | CN1628107A Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 06/15/2005 | CN1627955A Hepatocurative effect of emblica officinalis on hepatotoxicity related to cytoch rome P-45O |
| 06/15/2005 | CN1627954A Pharmaceutical compsn. contg. extract from barleria prionitis linn and its process of prepn |
| 06/15/2005 | CN1627944A Substituted quinazolin-4-ylamine analogues as modulators of capsaicin |
| 06/15/2005 | CN1626208A Preparation of fleabane and preparation method |
| 06/15/2005 | CN1626083A Powder and injection preparation of hydrochloric naloxone and preparation method |
| 06/15/2005 | CN1626077A Treatment of nuerodegenerative diseases |
| 06/15/2005 | CN1626068A Combination of medication in use for improving dissolution of curcumin and bioavailability as well as preparation method |
| 06/15/2005 | CN1625964A Capsule of natural protein containing selenium and American ginseng |
| 06/15/2005 | CN1625963A Capsule of natural protein containing selenium and root of pilose asiabell |
| 06/15/2005 | CN1206133C Infusion packet and its use |
| 06/15/2005 | CN1205984C Medicine composition with synergrstic action and preparation process and use thereof |
| 06/15/2005 | CN1205946C Formulation for clearing away heat and toxic material |
| 06/15/2005 | CN1205935C Highly selective norepinephrine reuptake inhibitors and methods of using same |
| 06/14/2005 | US6906100 Optionally esterified 5-ethylidene-4-carboxy-2-pyranones as a cytoprotective agent |
| 06/14/2005 | US6906082 Cholesteryl ester transfer protein inhibitor; anticholesterol agents, cardiovascular disorders; synergistic mixture |
| 06/14/2005 | US6906059 Administering cardioprotective amount of a benzazepin-N-acetic acid derivative for inhibiting or treating heart damage induced by a cardiotoxic medicamet in a mammal |
| 06/14/2005 | US6905688 Comprises therapeutic fusion proteins for diagnosis and treatment of cancers, neovascularization and autoimmune diseases |
| 06/09/2005 | US20050124696 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance |
| 06/09/2005 | US20050124665 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance |
| 06/09/2005 | US20050124554 Spermidine derivatives for the treatment of chronic neurodegenerative diseases |
| 06/09/2005 | US20050124004 Histamine receptor h3 polynucleotides |
| 06/09/2005 | US20050123662 Soybean saponin-containing material and process for producing the same |
| 06/09/2005 | US20050123633 Obtained by fermenting soybean germ, which is used as raw material, with koji mold, thus breaking down proteins, then hydrolyzing, extracting and concentrating using solvent to produce an isoflavone aglycone concentrate |
| 06/09/2005 | US20050123576 Mupirocin compositions for topical use, an improved process of making same and methods of using same |
| 06/09/2005 | US20050123575 Heating, cooling, reheating and recooling a mixture containing hard fat while stirring; cosmetics, cosmeceutical, pharmaceutical; second temperature is lower than the congelation temperature of the mixture; hard fat is a mixture of triester of glycerin with caprylic, capric and stearic acids |
| 06/08/2005 | EP1537861A2 Use of aminothiol compounds for the treatment xerostomia caused by therapeutic agents or radiation |
| 06/08/2005 | EP1537857A1 Mupirocin compositions for topical use, a process of making same and uses thereof |
| 06/08/2005 | EP1537110A2 Triazospiro compounds having nociceptin receptor affinity |
| 06/08/2005 | EP1536823A1 Use of erythopoietin |
| 06/08/2005 | EP1536801A2 Topical compositions and methods for treatment of adverse effects of ionizing radiation |
| 06/08/2005 | EP1265595B1 Stabilized ascorbic acid solutions |
| 06/08/2005 | CN1205205C Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 06/02/2005 | US20050119350 Treatment of effect of chemicals with their ultradilute stereoisomers |
| 06/02/2005 | US20050118219 1,3,6-trihydroxy-7-methoxy-2,8-di (3-methyl-2-butenyl) xanthone; rosacea and/or telangiectasia, skin aging |
| 06/01/2005 | EP1535919A2 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 06/01/2005 | EP1534720A1 Mitochondrially targeted antioxidants |
| 06/01/2005 | EP1534698A1 Flavonoid compounds as therapeutic antioxidants |
| 06/01/2005 | EP1534687A1 Pyrimidine compounds |
| 06/01/2005 | EP1534668A1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 06/01/2005 | EP1453820B1 Substituted 6h-dibenzo[c,h]chromenes as estrogenic agents |
| 06/01/2005 | EP1404330B1 Substituted 8-arylquinoline pde4 inhibitors |
| 06/01/2005 | EP1345902B1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 06/01/2005 | EP1280526B1 Use of 2-iminobiotin for the manufacture of a medicament for the prevention and/or treatment, in newborn babies, of the effects of complications during childbirth |
| 06/01/2005 | EP1253904B1 Use of extracts from residues left in the production of wine as cosmetic care actives for skin and hair |
| 06/01/2005 | CN1622946A Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| 06/01/2005 | CN1203899C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy |
| 06/01/2005 | CN1203851C Use of inhibitor produced or released by reactive oxygen metablite in producing pharmaceutical |
| 06/01/2005 | CN1203777C Universal detoxicant |
| 05/31/2005 | US6900338 Scavenger compounds |
| 05/31/2005 | US6900043 Phosphatases which activate map kinase pathways |
| 05/26/2005 | WO2005046567A2 Synergistic formulation of antioxidants and antimycobacterial agents: a method of making the same |
| 05/26/2005 | US20050113312 2-0-(-d-glucopyranosyl) ascorbic acid, process for its production, and foods and cosmetics containning compositions comprising it |
| 05/26/2005 | US20050113304 Recombinant expression system for production of a peptide capable of inhibiting the protease activity of Botulinum toxin B or tetanus toxin which expression system comprises a nucleotide sequence encoding the peptide operably linked to a control sequence for effecting expression |
| 05/25/2005 | EP1531851A2 Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use |
| 05/25/2005 | EP1531808A1 Peroxynitrite rearrangement catalysts used for the treatment or prophylaxis of diseases caused by peroxynitrite-mediated reactions |